Meng 2014.
Methods | Randomised clinical trial, China | |
Participants | 64 hospitalised adults with hepatocellular carcinoma and cirrhosis, at nutritional risk due to hepatectomy Male:Female = 39:25 Mean age = 51 years Exclusion criteria: none specified |
|
Interventions | Enteral nutrition suspension (TP‐MCT) 500ml (1 bottle/day) orally on 3rd preoperative day, using jejunal nutrient canal with 500 ml normal saline during operation for 12 hrs, and enteral nutrition suspension (TP‐MCT) 1000 ml on postoperative days 2 to 4; Based on co‐intervention. Total treatment duration was 7 days.(n = 55) Control: treatment as usual (n = 54) |
|
Outcomes | Biomarkers, adverse events, complications | |
Study dates | Not stated | |
Notes | We tried to contact the authors by phone and by email: mengfl.123@163.com. We received no reply. | |
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Low risk | Random‐number table |
Allocation concealment (selection bias) | Unclear risk | Not described |
Blinding of participants and personnel (performance bias) All outcomes | High risk | Participants and personnel were not blinded. |
Blinding of outcome assessment (detection bias) All outcomes | Unclear risk | Not described |
Incomplete outcome data (attrition bias) All outcomes | Unclear risk | The number of participants with incomplete data was not described. |
Selective reporting (reporting bias) | Low risk | No protocol but the trial reported on all‐cause mortality and serious adverse events. |
For‐profit bias | Unclear risk | It was unclear how the trial was funded. |
Other bias | Low risk | The trial appeared to be free of other components that could put it at risk of bias. |